Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Myelodysplastic Syndromes 16Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Non-Hodgkin 10Lymphoma 9Multiple Myeloma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia 8Recurrence 6Hodgkin Disease 6Myeloproliferative Disorders 5Lymphoma, Mantle-Cell 5Lymphoma, B-Cell 5Leukemia, Biphenotypic, Acute 5Neoplasms 4Neoplasm, Residual 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Juvenile 4Leukemia, Lymphoid 4Immunoproliferative Disorders 4Immune System Diseases 4Burkitt Lymphoma 4Precancerous Conditions 3Lymphoproliferative Disorders 3Lymphoma, B-Cell, Marginal Zone 3Lymphatic Diseases 3Leukemia, Myelomonocytic, Chronic 3

Interventions

Cisplatin 9pembrolizumab 8Radiotherapy, Intensity-Modulated 6Radiotherapy 5Carboplatin 5cemiplimab 4Paclitaxel 4durvalumab 3Surveys and Questionnaires 3Nivolumab 3tremelimumab 2Taxes 2Radiation 2olaparib 1niraparib 1lirilumab 1linrodostat 1fludarabine phosphate 1fludarabine 1dostarlimab 1bavituximab 1atezolizumab 1alpha-2'-deoxythioguanosine 1aldesleukin 1Tiragolumab 1Standard of Care 1Specimen Handling 1Radiotherapy, Image-Guided 1Proton Therapy 1Platinum Compounds 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Squamous Cell × fludarabine phosphate × Clear all
NCT06236425 2026-04-01

TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Active not recruiting
7 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡